Corona virus infection in pregnancy


The Journal of Clinical and Experimental Pathology (ISSN: 2161-0681) deals with research on infectious disorders associated with immune system and immunological disorders, infectious diseases, treatment of infectious diseases, infectious medicine, epidemiology, diagnostic tests of infectious diseases, infection control, pathophysiology, clinical pathology , preventive medicine. Clinical Pathology deals with patient care, diagnostic services, novel treatments and research on immune infections. Journal of Clinical & Experimental Pathology covers all areas of clinical and experimental pathology. Articles such as research papers, review articles, commentaries and short communications leading to the development of Journal of clinical and experimental pathology.

Viral infections in pregnancy and puerperium remain a significant cause of morbidity and mortality. A variety of viruses have been shown to be culprits of adverse outcomes in pregnancy. In particular, Human Immunodeficiency Virus, Influenza viruses, Cytomegalovirus, Varicella-Zoster Virus, Herpes Simplex Virus, Epstein-Barr Virus, Measles Virus, Rubella Virus, Zika Virus, Parvovirus B19 Virus, Coxsackie Viruses, Echoviruses, Hepatitis Viruses (HAV, HBV, HCV, HDV, HEV) and Lymphocytic Choriomeningitis Virus are all known to effect the health of pregnant mothers and potentially also the foetus. In addition, the new Coronavirus SARS-CoV-2 also affects pregnant women however the specific impact is unclear. It is beyond doubt that the clinical impact of these infections is of paramount significance and therefore current information on outcomes, therapeutic interventions where available and preventive measures are of particular interest.

As such, this Research Topic aims to address the clinical impact of viral diseases in pregnancy and the puerperium by providing an overview of clinical outcomes (morbidity, mortality, prognosis) of the pregnant woman as well as of the embryo or infant, and further, therapeutic interventions including measures of prevention of the aforementioned viral diseases.

On the occasion of its 10 years, Successful Journey, Journal of Clinical and Experimental Pathology decided to provide a partial waiver on its article processing charges to promote quality research from across the nations of the globe to encourage the latest research in the field of Infections, Diseases and Medicine. Journal of Clinical and Experimental Pathology also planning to release a special issue on its new approaches.


Robert Solomon

Editorial office

Journal of Clinical and Experimental Pathology


Reach Us: +1-947-333-4405